PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Korean Journal of Ophthalmology10.3341/kjo.2015.29.2.1152015292115Clinical Outcomes of Individualized Botulinum Neurotoxin Type A Injection Techniques in Patients with Essential BlepharospasmYoungje Sung, Sang Min Nam, Helen Lewhttps://synapse.koreamed.org/DOIx.php?id=10.3341/kjo.2015.29.2.115, https://synapse.koreamed.org/pdf/10.3341/kjo.2015.29.2.115, http://synapse.koreamed.org/DOIx.php?id=10.3341/kjo.2015.29.2.115
Toxins10.3390/toxins11010051201911151Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical FeaturesKazuya Yoshidahttp://www.mdpi.com/2072-6651/11/1/51/pdf
Scientific Reports10.1038/s41598-018-26750-5201881Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasmRen-Wen Ho, Po-Chiung Fang, Tsai-Ling Chao, Chun-Chih Chien, Ming-Tse Kuohttps://www.nature.com/articles/s41598-018-26750-5.pdf, https://www.nature.com/articles/s41598-018-26750-5, https://www.nature.com/articles/s41598-018-26750-5.pdf
Clinical & Experimental Ophthalmology10.1111/j.1442-9071.2010.02303.x2010387688-691Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasmPaul S Cannon, Kenneth R MacKenzie, Anne E Cook, Brian Leatherbarrowhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1442-9071.2010.02303.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1442-9071.2010.02303.x/fullpdf
Korean Journal of Ophthalmology10.3341/kjo.2017.003020183211Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential BlepharospasmSeunghyun Lee, Sangrye Park, Helen Lewhttps://synapse.koreamed.org/pdf/10.3341/kjo.2017.0030, https://synapse.koreamed.org/DOIx.php?id=10.3341/kjo.2017.0030, https://synapse.koreamed.org/DOIx.php?id=10.3341/kjo.2017.0030
Toxicon10.1016/j.toxicon.2018.11.0972018156S40Motor nerve sprouting and neuromuscular junction remodeling of orbicularis oculi muscles from patients with blepharospasm treated with botulinum neurotoxin type ABrigitte Girard, Aurélie Couesnon, Michel-Robert Popoff, Jordi Molgóhttps://api.elsevier.com/content/article/PII:S0041010118308183?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0041010118308183?httpAccept=text/plain
Acta Ophthalmologica10.1111/aos.120022013912e108-e112Tear production and drainage after botulinum toxin A injection in patients with essential blepharospasmDae Il Park, Hyun Min Shin, Sang Yeul Lee, Helen Lewhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Faos.12002
Clinical Parkinsonism & Related Disorders10.1016/j.prdoa.2022.10016020227100160Patient selection and injection techniques for botulinum neurotoxin in oromandibular dystoniaRoongroj Bhidayasiri, Suppata Maytharakcheep, Daniel D. Truonghttps://api.elsevier.com/content/article/PII:S2590112522000317?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2590112522000317?httpAccept=text/plain
Botulinum Toxin - Recent Topics and Applications10.5772/intechopen.1028962022Clinical Relevance of Neutralizing Antibodies in Botulinum Neurotoxin Type AHarald Hefter, Sara Samadzadehhttp://www.intechopen.com/download/pdf/81715
Toxins10.3390/toxins1411076920221411769Frequency of Hemorrhagic Side Effects of Botulinum Neurotoxin Treatment in Patients with Blepharospasm and Hemifacial Spasm on Antithrombotic MedicationFiona Carolin Wenninger, Bettina Wabbelshttps://www.mdpi.com/2072-6651/14/11/769/pdf